17 employees
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
2018
$28M
from 4 investors over 4 rounds
AZAFAROS B.V. raised $28M on February 6, 2020
Investors: BGV (BioGeneration Ventures), Forbion and BioMedPartners
AZAFAROS B.V. raised undisclosed on July 23, 2018
Investors: BGV (BioGeneration Ventures)